Evidence map›Paper›PMID 20862548›Full record

ArticleMycopathologia2011

Trichosporon inkin Esophagitis: An Uncommon Disease in a Patient with Pulmonary Cancer.

Danielle Patrícia Cerqueira Macêdo, Neiva Tinti de Oliveira, Vanessa Karina Alves da Silva, Aline Mary de Almeida Farias, Reginaldo Gonçalves de Lima Neto, Ana Botler Wilheim, Patrícia Cariolano de Oliveira, Nadyr Pedi, Suanni Lemos de Andrade, Rejane Pereira Neves

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Rare Yeasts in Latin America: Uncommon Yet Meaningful.Journal of fungi (Basel, Switzerland) · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Danielle Patrícia Cerqueira MacêdoDepartamento de Micologia, Centro de Ciências Biológicas, Universidade Federal de Pernambuco, Avenida Nelson Chaves, s/n, Cidade Universitária, Recife, PE, 50670-420, Brazil. danielle_xande@yahoo.com.br
Neiva Tinti de Oliveira
Vanessa Karina Alves da Silva
Aline Mary de Almeida Farias
Reginaldo Gonçalves de Lima Neto
Ana Botler Wilheim
Patrícia Cariolano de Oliveira
Nadyr Pedi
Suanni Lemos de Andrade
Rejane Pereira Neves
Universidade Federal de Pernambuco · BRHospital Universitário Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trichosporon species are usually opportunistic pathogens. Here, we present a case of esophagitis caused by T. inkin in a 54-year-old woman with pulmonary cancer and severe neutropenia in whom the susceptibility profile of the isolate against azoles and polyenes was verified. The patient was diagnosed with esophagitis grade I of Wilcox, presenting scattered whitish plaques and exudates in upper two-thirds of the esophageal mucosa. Antifungal therapy involving oral fluconazole (150 mg/day for 14 days) was ineffective. In vitro, the isolate showed no resistance to this azole and sensitivity to amphotericin B. Since T. inkin is of growing importance as an agent of invasive infections in immunocompromised patients, we stress that the diagnosis of esophagitis by this species should be followed by an assessment of the therapeutic sensitivity of the strain involved.

Indexed as

Antifungal AgentsAzolesEsophagitisEsophagoscopyEsophagusFemaleHumansImmunocompromised HostLung NeoplasmsMicrobial Sensitivity TestsMicroscopyMiddle AgedMycosesNeutropeniaPolyenesTreatment FailureAntifungal AgentsAzolesPolyenes

Identifiers

PMID20862548
OpenAlexW2087561912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.